Background. Heart transplant (HTx) recipients risk acquiring hepatotropic viral infections such as hepatitis B virus (HBV) and hepatitis C virus (HCV), and the impact of these infections on post-HTx survival remains unclear. The aim of the present study was to define the prevalence, clinical features, and natural history of HBV and HCV infections in a cohort of HTx recipients. Methods. We retrospectively studied 360 consecutive patients who had undergone HTx. Clinical picture, hepatic injury indexes, and HBV/HCV viral serology were followed post-transplant. Results. During follow-up (average, 8 ± 3.1 years), 49 (16.5%) of the HTx recipients tested positive for at least 1 of the 2 viruses (3.1% HBV, 12% HCV, 0.5% concomitant infection). The prevalence of HCV infection in heart transplant recipients transplanted before and after 1990 was 28% and 4.2%, respectively, the latter being markedly lower (p < 0.001) than in earlier series of HTx recipients and much lower than expected in the age- and sex-matched general population. All HBV-positive and 58% of HCV-positive recipients developed chronic liver disease. Sixteen percent of patients developed cirrhosis during follow-up, and 8% died of end-stage liver disease. Conclusions. The prevalence of HBV and HCV in a large population of HTx recipients is not very different from that reported in the general population. Active viral replication of HBV and an aggressive natural history of both infections are seen in HTx recipients, however. The low prevalence of HBV- and HCV-related infection in recent series probably reflects current viral screening and vaccination policies.

Fagiuoli, S., Minniti, F., Pevere, S., Farinati, F., Burra, P., Livi, U., et al. (2001). HBV and HCV infections in heart transplant recipients. THE JOURNAL OF HEART AND LUNG TRANSPLANTATION, 20(7), 718-724 [10.1016/s1053-2498(01)00255-8].

HBV and HCV infections in heart transplant recipients

FAGIUOLI S
;
2001

Abstract

Background. Heart transplant (HTx) recipients risk acquiring hepatotropic viral infections such as hepatitis B virus (HBV) and hepatitis C virus (HCV), and the impact of these infections on post-HTx survival remains unclear. The aim of the present study was to define the prevalence, clinical features, and natural history of HBV and HCV infections in a cohort of HTx recipients. Methods. We retrospectively studied 360 consecutive patients who had undergone HTx. Clinical picture, hepatic injury indexes, and HBV/HCV viral serology were followed post-transplant. Results. During follow-up (average, 8 ± 3.1 years), 49 (16.5%) of the HTx recipients tested positive for at least 1 of the 2 viruses (3.1% HBV, 12% HCV, 0.5% concomitant infection). The prevalence of HCV infection in heart transplant recipients transplanted before and after 1990 was 28% and 4.2%, respectively, the latter being markedly lower (p < 0.001) than in earlier series of HTx recipients and much lower than expected in the age- and sex-matched general population. All HBV-positive and 58% of HCV-positive recipients developed chronic liver disease. Sixteen percent of patients developed cirrhosis during follow-up, and 8% died of end-stage liver disease. Conclusions. The prevalence of HBV and HCV in a large population of HTx recipients is not very different from that reported in the general population. Active viral replication of HBV and an aggressive natural history of both infections are seen in HTx recipients, however. The low prevalence of HBV- and HCV-related infection in recent series probably reflects current viral screening and vaccination policies.
Articolo in rivista - Articolo scientifico
HBV; HCV; heart transplant recipients;
English
718
724
7
Fagiuoli, S., Minniti, F., Pevere, S., Farinati, F., Burra, P., Livi, U., et al. (2001). HBV and HCV infections in heart transplant recipients. THE JOURNAL OF HEART AND LUNG TRANSPLANTATION, 20(7), 718-724 [10.1016/s1053-2498(01)00255-8].
Fagiuoli, S; Minniti, F; Pevere, S; Farinati, F; Burra, P; Livi, U; Naccarato, R; Chiaramonte, M
File in questo prodotto:
File Dimensione Formato  
Fagiuoli S. (2001) HBV and HCV infections in heart transplant recipients..pdf

Solo gestori archivio

Dimensione 3.99 MB
Formato Adobe PDF
3.99 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/354091
Citazioni
  • Scopus 36
  • ???jsp.display-item.citation.isi??? 33
Social impact